HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alpha Tau Medical (NASDAQ: DRTS) and maintained a price target of $16 for the stock.